MXPA03005770A - Composiciones medicinales que contienen aspirina. - Google Patents
Composiciones medicinales que contienen aspirina.Info
- Publication number
- MXPA03005770A MXPA03005770A MXPA03005770A MXPA03005770A MXPA03005770A MX PA03005770 A MXPA03005770 A MX PA03005770A MX PA03005770 A MXPA03005770 A MX PA03005770A MX PA03005770 A MXPA03005770 A MX PA03005770A MX PA03005770 A MXPA03005770 A MX PA03005770A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions containing
- medicinal compositions
- pharmaceutical compositions
- containing aspirin
- aspirin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000392983 | 2000-12-25 | ||
PCT/JP2001/011201 WO2002051412A1 (fr) | 2000-12-25 | 2001-12-20 | Compositions medicales contenant de l'aspirine |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03005770A true MXPA03005770A (es) | 2003-09-10 |
Family
ID=18858878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03005770A MXPA03005770A (es) | 2000-12-25 | 2001-12-20 | Composiciones medicinales que contienen aspirina. |
Country Status (26)
Country | Link |
---|---|
US (3) | US20040024013A1 (es) |
EP (1) | EP1350511B1 (es) |
KR (1) | KR100692934B1 (es) |
CN (1) | CN100341506C (es) |
AT (1) | ATE407675T1 (es) |
AU (1) | AU2002217464B2 (es) |
BR (1) | BR0116531A (es) |
CA (1) | CA2432644C (es) |
CY (1) | CY1108626T1 (es) |
CZ (1) | CZ297570B6 (es) |
DE (1) | DE60135780D1 (es) |
DK (1) | DK1350511T3 (es) |
ES (1) | ES2311498T3 (es) |
HK (1) | HK1056118A1 (es) |
HU (1) | HUP0400644A3 (es) |
IL (2) | IL156456A0 (es) |
MX (1) | MXPA03005770A (es) |
NO (1) | NO20032902L (es) |
NZ (1) | NZ526540A (es) |
PL (1) | PL206138B1 (es) |
PT (1) | PT1350511E (es) |
RU (1) | RU2262933C2 (es) |
SK (1) | SK287972B6 (es) |
TW (1) | TWI293249B (es) |
WO (1) | WO2002051412A1 (es) |
ZA (1) | ZA200304878B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60134508D1 (de) * | 2000-07-06 | 2008-07-31 | Daiichi Sankyo Co Ltd | Säure-Additionssalze von Hydropyridinderivaten |
EP1350511B1 (en) | 2000-12-25 | 2008-09-10 | Daiichi Sankyo Company, Limited | Medicinal compositions containing aspirin |
EP1660183A2 (en) * | 2003-05-05 | 2006-05-31 | Eli Lilly and Company | Treating cardiovascular diseases with a compound of formula 1 (cs 747 - prasugrel; rn 150322-43-4) |
CN100488163C (zh) * | 2005-01-19 | 2009-05-13 | 华为技术有限公司 | 组播业务处理方法和系统 |
US20090156632A1 (en) * | 2005-06-17 | 2009-06-18 | John Thomas Brandt | Dosage regimen for prasugrel |
DE102005029612A1 (de) * | 2005-06-23 | 2007-01-04 | Hochschule Bremen | Vorrichtung zum Erzeugen eines Panoramabildes |
WO2007024472A2 (en) * | 2005-08-19 | 2007-03-01 | Eli Lilly And Company | USE OF PAR- l/PAR- 4 INHIBITORS FOR TREATING OR PREVENTING VASCULAR DISEASES |
SI2032521T1 (sl) * | 2006-06-27 | 2010-02-26 | Sandoz Ag | Nov postopek za pripravo soli |
CA2672154C (en) * | 2006-12-07 | 2014-11-18 | Daiichi Sankyo Company, Limited | Pharmaceutical composition having improved storage stability |
TWI442947B (zh) * | 2006-12-07 | 2014-07-01 | Daiichi Sankyo Co Ltd | 安定性經改善之薄膜塗覆製劑 |
EP2100608A4 (en) * | 2006-12-07 | 2009-12-09 | Daiichi Sankyo Co Ltd | METHOD FOR PRODUCING A SOLID PREPARATION |
JP5274261B2 (ja) * | 2006-12-07 | 2013-08-28 | 第一三共株式会社 | 低置換度ヒドロキシプロピルセルロースを含有する医薬組成物 |
KR101442862B1 (ko) * | 2006-12-07 | 2014-09-22 | 다이이찌 산쿄 가부시키가이샤 | 만니톨 또는 유당을 함유하는 고형 제제 |
MX2009009413A (es) * | 2007-03-02 | 2009-09-11 | Daiichi Sankyo Co Ltd | Metodo para la produccion de clorhidrato de prasugrel de alta pureza. |
WO2008134600A1 (en) | 2007-04-27 | 2008-11-06 | Cydex Pharmaceuticals, Inc. | Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use |
CN101177430A (zh) * | 2007-12-11 | 2008-05-14 | 鲁南制药集团股份有限公司 | 氢化吡啶衍生物及其盐的制备方法 |
US20090281136A1 (en) * | 2008-05-08 | 2009-11-12 | Sandeep Mhetre | Prasugrel pharmaceutical formulations |
KR20110045034A (ko) | 2008-08-02 | 2011-05-03 | 루난 파마슈티컬 그룹 코퍼레이션 | 프라수그렐 황산수소염 및 이의 약제학적 조성물 및 용도 |
KR20190071006A (ko) | 2009-05-13 | 2019-06-21 | 사이덱스 파마슈티칼스, 인크. | 프라수그렐 및 사이클로덱스트린 유도체를 포함하는 약학 조성물 및 그의 제조 및 사용 방법 |
CN102228691A (zh) * | 2011-06-29 | 2011-11-02 | 北京阜康仁生物制药科技有限公司 | 阿司匹林和一种抗血小板药物的药物组合物 |
US9757395B2 (en) * | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
US9757529B2 (en) * | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
CA2910766C (en) | 2013-04-30 | 2020-12-15 | Otitopic Inc. | Dry powder formulations and methods of use |
PL3107548T3 (pl) | 2014-02-20 | 2022-10-31 | Otitopic Inc. | Suche formulacje w proszku do inhalacji |
WO2016122421A1 (en) | 2015-01-29 | 2016-08-04 | Pharmactive Ilaç Sanayi Ve Ticaret A.Ş. | Stable pharmaceutical compositions containing prasugrel base |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2890240A (en) * | 1956-03-28 | 1959-06-09 | Monsanto Chemicals | Aspirin crystallisation |
US3235583A (en) * | 1964-07-22 | 1966-02-15 | Norwich Pharma Co | Preparation of aspirin |
US3890240A (en) * | 1966-11-28 | 1975-06-17 | Pitney Bowes Inc | Toner compositions and methods for their preparation |
FR2215948B1 (es) | 1973-02-01 | 1976-05-14 | Centre Etd Ind Pharma | |
FR2345150A2 (fr) | 1975-08-06 | 1977-10-21 | Centre Etd Ind Pharma | Nouveaux derives de la thienopyridine, et leur application |
FR2307538A1 (fr) * | 1975-04-18 | 1976-11-12 | Centre Etd Ind Pharma | Nouveau medicament anti-agregant plaquettaire |
FR2312247A1 (fr) | 1975-05-30 | 1976-12-24 | Parcor | Derives de la thieno-pyridine, leur procede de preparation et leurs applications |
FR2358150A1 (fr) * | 1976-07-13 | 1978-02-10 | Parcor | Nouvelles thieno (2,3-c) et (3,2-c) pyridines, leur procede de preparation et leur application |
FR2376860A1 (fr) * | 1977-01-07 | 1978-08-04 | Parcor | Tetrahydro-4,5,6,7 thieno (2,3-c) et (3,2-c) pyridines, leur procede de preparation et leur application therapeutique |
GB1576511A (en) * | 1977-03-29 | 1980-10-08 | Parcor | Thieno(2,3 - c) and (3,2 - c) pyridines process for their preparation and therapeutic applications thereof |
GB2038625B (en) * | 1978-12-29 | 1983-01-12 | Parcor | Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity |
CA1147658A (en) | 1980-01-03 | 1983-06-07 | Edouard Panak | Therapeutic compositions having antithrombotic and anti-blood-platelet- aggregating activity |
US4400384A (en) * | 1980-10-06 | 1983-08-23 | Sanofi, S.A. | 5-o-Cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-c] pyridine methanesulfonate and other novel salts thereof |
US4321266A (en) * | 1980-10-06 | 1982-03-23 | Sanofi | 5-o-Cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-C] pyridine |
FR2495156A1 (fr) * | 1980-11-28 | 1982-06-04 | Sanofi Sa | Derives de la thieno-pyridinone, leur procede de preparation et leur application therapeutique |
FR2528848A1 (fr) * | 1982-06-16 | 1983-12-23 | Sanofi Sa | Nouveau derive de thieno-pyridone, son procede de preparation et son application therapeutique |
FR2530247B1 (fr) * | 1982-07-13 | 1986-05-16 | Sanofi Sa | Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique |
FR2576901B1 (fr) * | 1985-01-31 | 1987-03-20 | Sanofi Sa | Nouveaux derives de l'acide a-(oxo-2 hexahydro-2,4,5,6,7,7a thieno (3,2-c) pyridyl-5) phenyl acetique, leur procede de preparation et leur application therapeutique |
FR2596392B1 (fr) | 1986-03-27 | 1988-08-05 | Sanofi Sa | Derives de l'acide a-(hydroxy-3 oxo-2 hexahydro-2,4,5,6,7,7a thieno (3,2-c) pyridyl-5) phenylacetique, leur procede de preparation, leur application comme medicaments et les compositions les renfermant |
FR2597102B1 (fr) | 1986-04-14 | 1988-08-26 | Sanofi Sa | Derives de l'acide a-(hydroxy-7 tetrahydro-4,5,6,7 thieno (3,2-c) pyridyl-5) phenyl acetique, leur procede de preparation, leur application comme medicament et les compositions les renfermant |
FR2652579B1 (fr) * | 1989-10-02 | 1992-01-24 | Sanofi Sa | Derives d'hydroxy-2 thiophene et furanne condenses avec un cycle azote, sur procede de preparation et leur application en therapeutique. |
US5401730A (en) * | 1990-07-06 | 1995-03-28 | The Hope Heart Institute | Method for reducing platelet aggregation |
FI101150B (fi) | 1991-09-09 | 1998-04-30 | Sankyo Co | Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi |
JP2712144B2 (ja) | 1992-02-06 | 1998-02-10 | 田辺製薬株式会社 | 血小板凝集抑制組成物 |
EP0573975A1 (en) | 1992-06-08 | 1993-12-15 | Fuji Photo Film Co., Ltd. | 2-alkoxycarbonyl-5-o-chlorobenzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine derivative and process for producing the same |
ATE166047T1 (de) | 1993-03-17 | 1998-05-15 | Meiji Seika Co | Neue verbindungen mit blutplättchenaggregationshemmender aktivität |
JPH06271582A (ja) | 1993-03-18 | 1994-09-27 | Fuji Photo Film Co Ltd | 4,5,6,7−テトラヒドロチエノ〔3,2−c〕ピリジン誘導体の製造方法 |
WO1996011203A1 (fr) * | 1994-10-07 | 1996-04-18 | Ube Industries, Ltd. | 2-silyloxytetrahydrothienopyridine, son sel, et son procede de production |
JP3564791B2 (ja) | 1995-04-21 | 2004-09-15 | 宇部興産株式会社 | α−アミノケトン類の製造方法 |
FR2744918B1 (fr) * | 1996-02-19 | 1998-05-07 | Sanofi Sa | Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique |
CA2332608C (en) * | 1998-06-17 | 2010-03-23 | Bristol-Myers Squibb Company | Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination |
US6509348B1 (en) * | 1998-11-03 | 2003-01-21 | Bristol-Myers Squibb Company | Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination |
IT1306980B1 (it) | 1999-01-13 | 2001-10-11 | Magneti Marelli Spa | Gruppo motore-cambio di velocita', in particolare per motocicli. |
CN1108798C (zh) * | 1999-01-26 | 2003-05-21 | 广东药学院 | 一种治疗、预防血栓形成及中风的复方制剂及其制备方法 |
JP2000266780A (ja) | 1999-03-18 | 2000-09-29 | Matsushita Electric Ind Co Ltd | プローブカードとそれを用いた検査装置 |
IT1311923B1 (it) | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
IT1311924B1 (it) | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
FR2792836B3 (fr) | 1999-04-30 | 2001-07-27 | Sanofi Sa | Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel |
MY125533A (en) * | 1999-12-06 | 2006-08-30 | Bristol Myers Squibb Co | Heterocyclic dihydropyrimidine compounds |
JP4001199B2 (ja) | 2000-07-06 | 2007-10-31 | 第一三共株式会社 | ヒドロピリジン誘導体酸付加塩 |
DE60134508D1 (de) | 2000-07-06 | 2008-07-31 | Daiichi Sankyo Co Ltd | Säure-Additionssalze von Hydropyridinderivaten |
US6642252B2 (en) * | 2000-11-07 | 2003-11-04 | Bristol-Myers Squibb Company | Acid derivatives useful as serine protease inhibitors |
EP1350511B1 (en) | 2000-12-25 | 2008-09-10 | Daiichi Sankyo Company, Limited | Medicinal compositions containing aspirin |
US6670386B2 (en) * | 2001-07-31 | 2003-12-30 | Bristol-Myers Squibb Company | Bicyclic modulators of androgen receptor function |
DE10305984A1 (de) * | 2003-02-13 | 2004-09-02 | Helm Ag | Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen |
EP1704152A2 (en) * | 2004-09-21 | 2006-09-27 | Teva Pharmaceutical Industries Ltd | Crystalline clopidogrel hydrobromide and processes for preparation thereof |
US20110003847A1 (en) * | 2008-02-06 | 2011-01-06 | Helm Ag | Prasugrel Salts with Improved Properties |
DE202008003557U1 (de) | 2008-03-13 | 2008-06-05 | Riela - Getreidetechnik Karl-Heinz Knoop E.K. | Schubwendetrockner mit Feuchte-Messeinrichtung |
PL2112155T3 (pl) | 2008-04-25 | 2011-03-31 | Sandoz Ag | Wodorosiarczan (VI) 2-acetoksy-5-(α-cyklopropylokarbonylo-2-fluorobenzylo)-4,5,6,7-tetrahydrotieno[3,2-c]pirydyny i sposób jego otrzymywania |
GB2469883A (en) | 2009-04-30 | 2010-11-03 | Sandoz Ag | Novel crystalline form of Prasugrel hydrogensulphate |
HU3745U (en) | 2009-10-01 | 2010-03-29 | Laszlo Borzan | Disk guide device for target disk launcher or bowler equipments |
-
2001
- 2001-12-20 EP EP01271850A patent/EP1350511B1/en not_active Revoked
- 2001-12-20 AU AU2002217464A patent/AU2002217464B2/en not_active Expired
- 2001-12-20 CN CNB018227686A patent/CN100341506C/zh not_active Expired - Lifetime
- 2001-12-20 NZ NZ526540A patent/NZ526540A/en not_active IP Right Cessation
- 2001-12-20 DK DK01271850T patent/DK1350511T3/da active
- 2001-12-20 KR KR1020037008323A patent/KR100692934B1/ko active IP Right Grant
- 2001-12-20 CZ CZ20031660A patent/CZ297570B6/cs not_active IP Right Cessation
- 2001-12-20 HU HU0400644A patent/HUP0400644A3/hu not_active Application Discontinuation
- 2001-12-20 BR BR0116531-3A patent/BR0116531A/pt not_active Application Discontinuation
- 2001-12-20 IL IL15645601A patent/IL156456A0/xx active IP Right Grant
- 2001-12-20 MX MXPA03005770A patent/MXPA03005770A/es active IP Right Grant
- 2001-12-20 AT AT01271850T patent/ATE407675T1/de active
- 2001-12-20 RU RU2003118638/15A patent/RU2262933C2/ru active
- 2001-12-20 CA CA2432644A patent/CA2432644C/en not_active Expired - Lifetime
- 2001-12-20 PL PL363183A patent/PL206138B1/pl unknown
- 2001-12-20 WO PCT/JP2001/011201 patent/WO2002051412A1/ja active IP Right Grant
- 2001-12-20 PT PT01271850T patent/PT1350511E/pt unknown
- 2001-12-20 DE DE60135780T patent/DE60135780D1/de not_active Expired - Lifetime
- 2001-12-20 SK SK754-2003A patent/SK287972B6/sk not_active IP Right Cessation
- 2001-12-20 ES ES01271850T patent/ES2311498T3/es not_active Expired - Lifetime
- 2001-12-25 TW TW090132160A patent/TWI293249B/zh not_active IP Right Cessation
-
2003
- 2003-06-16 IL IL156456A patent/IL156456A/en unknown
- 2003-06-20 US US10/600,266 patent/US20040024013A1/en active Granted
- 2003-06-23 ZA ZA200304878A patent/ZA200304878B/en unknown
- 2003-06-24 NO NO20032902A patent/NO20032902L/no unknown
- 2003-11-19 HK HK03108414.8A patent/HK1056118A1/xx not_active IP Right Cessation
-
2006
- 2006-09-13 US US11/520,168 patent/US8404703B2/en not_active Expired - Fee Related
-
2008
- 2008-01-03 US US12/006,546 patent/US8569325B2/en not_active Expired - Fee Related
- 2008-12-02 CY CY20081101387T patent/CY1108626T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1056118A1 (en) | Medicinal compositions containing aspirin | |
WO2001087329A8 (en) | Liquid pharmaceutical composition containing an erythropoietin derivate | |
CA2219742A1 (en) | N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists | |
IL212075A0 (en) | Pharmaceutical compositions comprising a combination of a renin inhibitor and at least one therapeutic agent and uses thereof for the manufacture of medicaments for the prevention of, delay of progression of, or treatment of a disease | |
CA2183972A1 (en) | Oxazolidinone derivatives and pharmaceutical compositions containing them | |
NO324227B1 (no) | Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer | |
EP1734041A3 (en) | Platelet ADP receptor inhibitors | |
CA2703697A1 (en) | Acid addition salts of hydropyridine derivatives | |
DK0816376T3 (da) | Thrombininhibitorer som antikoagulante midler | |
DE60134021D1 (de) | Pharmazeutische zubereitungen zur angiogenese-therapie | |
DE60008399D1 (de) | Carbonsäuren und acylsulfonamide, solche verbindungen enthaltende zubereitungen und behandlungsmethoden | |
SE0002729D0 (sv) | Novel compound form | |
HUP9802897A3 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
EP1065200A4 (en) | Aminoisoquinoline DERIVATIVES | |
WO2000066550A8 (en) | New compounds | |
EP0373771A3 (en) | New pharmaceutical uses for cystatins | |
HRP20020989B1 (en) | Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer | |
CA2260863A1 (en) | Treatment of psychotic disorders | |
WO2002078633A3 (en) | Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia | |
AU2001274000A1 (en) | Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them | |
WO2002036105A3 (en) | Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders | |
HUP9802437A3 (en) | 5-pyrazolylbenzoic acid derivatives, herbicidal, desiccant and defoliant compositions containing these compounds as active ingredients, preparation and use of the latest | |
GEP20043356B (en) | Compounds Useful For Treatment or Prevention of Diseases Mediated By Alpha- 2B-Adrenoceptor | |
HUP9802896A3 (en) | Optically active piperidinoalkyl-4h-1,2,4-oxadiazine derivative, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
WO1998042312A3 (en) | Medicament having sclerosing activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
GB | Transfer or rights |